Here are five notes from the recommendations:
- The update includes refinement of definitions, reporting terms and grading for cardiovascular adverse events.
- Event adjudication is recommended for complex or rare cardiovascular events such as myocarditis to improve accuracy in classification.
- Trial sites should be educated on recognizing and correctly reporting cardiovascular events. Baseline tests should be used to identify potential adverse events earlier.
- Data collection should be standardized to ensure consistent reporting across trial sites and promote accurate assessment of clinical outcomes.
- Trial sites are encouraged to collaborate with cardiologists as evidence of cancer therapies’ effect on cardiovascular health grows.
Read the full recommendations here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
